These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38044545)

  • 41. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
    Mittal N; Mittal R
    Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response.
    Sawyer LM; Cornic L; Levin LÅ; Gibbons C; Møller AH; Jemec GB
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):355-366. PubMed ID: 30289198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis.
    Szebényi J; Gede N; Hegyi P; Szakács Z; Solymár M; Erőss B; Garami A; Farkas K; Csupor D; Gyulai R
    Acta Derm Venereol; 2020 Nov; 100(18):adv00318. PubMed ID: 32965504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness comparisons of traditional Chinese medicine for psoriasis: A Bayesian network meta-analysis.
    Wang L; Tao Y; Deng S; Chu L; Li L
    Medicine (Baltimore); 2019 Sep; 98(36):e17055. PubMed ID: 31490403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis.
    Zhao H; Hodges JS; Ma H; Jiang Q; Carlin BP
    Stat Med; 2016 Sep; 35(20):3524-36. PubMed ID: 27037506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Bayesian hierarchical model for network meta-analysis of multiple diagnostic tests.
    Ma X; Lian Q; Chu H; Ibrahim JG; Chen Y
    Biostatistics; 2018 Jan; 19(1):87-102. PubMed ID: 28586407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis.
    Shi J; Xu J; Chen Y
    Dermatol Ther; 2020 Jul; 33(4):e13802. PubMed ID: 32521069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting relationships between outcomes in Bayesian multivariate network meta-analysis with an application to relapsing-remitting multiple sclerosis.
    Waddingham E; Matthews PM; Ashby D
    Stat Med; 2020 Oct; 39(24):3329-3346. PubMed ID: 32672370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bayesian meta-analysis using SAS PROC BGLIMM.
    Rott KW; Lin L; Hodges JS; Siegel L; Shi A; Chen Y; Chu H
    Res Synth Methods; 2021 Nov; 12(6):692-700. PubMed ID: 34245227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias.
    Thom H; Leahy J; Jansen JP
    Med Decis Making; 2022 Oct; 42(7):906-922. PubMed ID: 35531938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When does the use of individual patient data in network meta-analysis make a difference? A simulation study.
    Kanters S; Karim ME; Thorlund K; Anis A; Bansback N
    BMC Med Res Methodol; 2021 Jan; 21(1):21. PubMed ID: 33435879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interpreting and assessing confidence in network meta-analysis results: an introduction for clinicians.
    Yang A; Pechlivanoglou P; Aoyama K
    J Anesth; 2022 Aug; 36(4):524-531. PubMed ID: 35641661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.
    Ruyssen-Witrand A; Perry R; Watkins C; Braileanu G; Kumar G; Kiri S; Nott D; Liu-Leage S; Hartz S; Sapin C
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32094304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothesis testing in Bayesian network meta-analysis.
    Uhlmann L; Jensen K; Kieser M
    BMC Med Res Methodol; 2018 Nov; 18(1):128. PubMed ID: 30419827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dressings and topical agents for treating pressure ulcers.
    Westby MJ; Dumville JC; Soares MO; Stubbs N; Norman G
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011947. PubMed ID: 28639707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degree irregularity and rank probability bias in network meta-analysis.
    Davies AL; Galla T
    Res Synth Methods; 2021 May; 12(3):316-332. PubMed ID: 32935913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dressings and topical agents for treating venous leg ulcers.
    Norman G; Westby MJ; Rithalia AD; Stubbs N; Soares MO; Dumville JC
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012583. PubMed ID: 29906322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multivariate network meta-analysis incorporating class effects.
    Owen RK; Bujkiewicz S; Tincello DG; Abrams KR
    BMC Med Res Methodol; 2020 Jul; 20(1):184. PubMed ID: 32641105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Markov chain approach for ranking treatments in network meta-analysis.
    Chaimani A; Porcher R; Sbidian É; Mavridis D
    Stat Med; 2021 Jan; 40(2):451-464. PubMed ID: 33105517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.